Opaleye Management Inc. Astria Therapeutics, Inc. Transaction History

Opaleye Management Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$8.33 - $13.72 $24,990 - $41,160	3,000 Added 0.99%	305,000 $2.54 Million
Q1 2023 May 12, 2023	BUY	$11.2 - $15.79 $451,326 - $636,289	40,297 Added 15.4%	302,000 $4.02 Million
Q4 2022 Feb 10, 2023	BUY	$7.44 - $14.89 $953,830 - $1.91 Million	128,203 Added 96.03%	261,703 $3.9 Million
Q3 2022 Nov 14, 2022	BUY	$2.97 - $10.34 $396,495 - $1.38 Million	133,500 New	133,500 $1.21 Million

107

48.6M

48K

9.3K

Ticker ATXS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,178,000
Market Cap $135M
Description
Astria Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare and niche allergic, and immunological diseases in the United States. Its lead product candidate is STAR-0215, a monoclonal antibody inhibitor of plasma kallikrein, which is in preclinical development stage...

Get notified when there are updates to the investment portfolio of Opaleye Management Inc., based on Form 13F filings with the SEC.

Stay updated on Opaleye Management Inc. with notifications on news.